I wish Ihad this info when I was first DXed./register.gotowebinar.com/register/537054644223479555?source=Facebook+registration
OVERVIEW: This presentation is an overview of the most common and serious side effects that are possible for men who are treated for prostate cancer. It compares and contrasts the 4 main treatment options: surgery, low dose rate (LDR; permanent seed) brachytherapy, high dose rate (HDR: temporary seed) brachytherapy, and external beam radiotherapy (EBRT). This is a presentation that men and their families who are still undecided as to what treatment option they prefer may find useful as it compares the risk of developing a side effect of therapy (e.g. bladder leaking, rectal bleeding, etc) between the four options. This presentation is based on the best available data in the medical literature that a collaborative group of surgeons and oncologists agreed upon to help make sure patients are provided consistent, high quality information.
SPEAKER: Dr. Danny Vesprini is a Radiation Oncologist specializing in Prostate Cancer at the Sunnybrook Odette Cancer Centre, Affiliate Scientist at the Sunnybrook Research Institute and an Assistant Professor at the University of Toronto. He is one of the Principle Investigators of the Sunnybrook Active Surveillance Program, the Director of the Male Oncology Research and Education (MORE) program which focuses on men that have developed or are at a high risk of developing aggressive prostate cancer.
DX in May 2011, Age 52, Stage T2c, GG 8-10, PSA=10.6
EBR + Brachy Seed Implants + HT(22.5 mg Lupron for 1 year)
Nov 2011,PSA 0,
Feb 2012, PSA 0 (T=1.66), Nov 2012, 0.29 T=4.0
May 2013 0.32 T=5.11, Nov 2013 - 0.20 T = normal
May 2014 0.22, Nov 2014 - 0.60,
May 2015, PSA=0.7 NEW- Nov 2015, PSA-0.18
May 2016, PSA=0.76, 5 years later 0.39 Nov 2016